{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:57:52Z","timestamp":1767851872418,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,26]]},"DOI":"10.7759\/cureus.74528","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T23:14:32Z","timestamp":1732662872000},"source":"Crossref","is-referenced-by-count":2,"title":["Metabolite Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Anthony","family":"Eze-odurukwe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lois","family":"Ayinla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabila N","family":"Anika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramsha","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amarachi L","family":"Ugwuoru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzafar","family":"Mansoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Kamran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel RL","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021, 71:7-33. 10.3322\/caac.21654","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.32","article-title":"Emerging applications of metabolomics in drug discovery and precision medicine","volume":"15","author":"Wishart DS","year":"2016","unstructured":"Wishart DS. Emerging applications of metabolomics in drug discovery and precision medicine. Nat Rev Drug Discov. 2016, 15:473-84. 10.1038\/nrd.2016.32","journal-title":"Nat Rev Drug Discov"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/metabo3030552","article-title":"A review of applications of metabolomics in cancer","volume":"3","author":"Beger RD","year":"2013","unstructured":"Beger RD. A review of applications of metabolomics in cancer. Metabolites. 2013, 3:552-74. 10.3390\/metabo3030552","journal-title":"Metabolites"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312432","article-title":"Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis","volume":"67","author":"Mayerle J","year":"2018","unstructured":"Mayerle J, Kalthoff H, Reszka R, et al.. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis. Gut. 2018, 67:128-37. 10.1136\/gutjnl-2016-312432","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132223","article-title":"A novel multivariate index for pancreatic cancer detection based on the plasma free amino acid profile","volume":"10","author":"Fukutake N","year":"2015","unstructured":"Fukutake N, Ueno M, Hiraoka N, et al.. A novel multivariate index for pancreatic cancer detection based on the plasma free amino acid profile. PLoS One. 2015, 10:e0132223. 10.1371\/journal.pone.0132223","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1021\/pr201001a","article-title":"Distinct urinary metabolic profile of human colorectal cancer","volume":"11","author":"Cheng Y","year":"2012","unstructured":"Cheng Y, Xie G, Chen T, et al.. Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res. 2012, 11:1354-63. 10.1021\/pr201001a","journal-title":"J Proteome Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3686","article-title":"Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development","volume":"20","author":"Mayers JR","year":"2014","unstructured":"Mayers JR, Wu C, Clish CB, et al.. Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med. 2014, 20:1193-8. 10.1038\/nm.3686","journal-title":"Nat Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1501605112","article-title":"Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors","volume":"112","author":"Daemen A","year":"2015","unstructured":"Daemen A, Peterson D, Sahu N, et al.. Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors. Proc Natl Acad Sci U S A. 2015, 112:E4410-7. 10.1073\/pnas.1501605112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9990768","article-title":"Metabolomics identifies biomarker signatures to differentiate pancreatic cancer from type 2 diabetes mellitus in early diagnosis","volume":"2021","author":"Xu H","year":"2021","unstructured":"Xu H, Zhang L, Kang H, Liu J, Zhang J, Zhao J, Liu S. Metabolomics identifies biomarker signatures to differentiate pancreatic cancer from type 2 diabetes mellitus in early diagnosis. Int J Endocrinol. 2021, 2021:9990768. 10.1155\/2021\/9990768","journal-title":"Int J Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.744667","article-title":"Potential metabolite biomarkers for early detection of stage-I pancreatic ductal adenocarcinoma","volume":"11","author":"Cao Y","year":"2021","unstructured":"Cao Y, Zhao R, Guo K, et al.. Potential metabolite biomarkers for early detection of stage-I pancreatic ductal adenocarcinoma. Front Oncol. 2021, 11:744667. 10.3389\/fonc.2021.744667","journal-title":"Front Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1210\/en.2019-00165","article-title":"Search for early pancreatic cancer blood biomarkers in five European prospective population biobanks using metabolomics","volume":"160","author":"Fest J","year":"2019","unstructured":"Fest J, Vijfhuizen LS, Goeman JJ, et al.. Search for early pancreatic cancer blood biomarkers in five European prospective population biobanks using metabolomics. Endocrinology. 2019, 160:1731-42. 10.1210\/en.2019-00165","journal-title":"Endocrinology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-1543","article-title":"Altered gene expression along the glycolysis-cholesterol synthesis axis is associated with outcome in pancreatic cancer","volume":"26","author":"Karasinska JM","year":"2020","unstructured":"Karasinska JM, Topham JT, Kalloger SE, et al.. Altered gene expression along the glycolysis-cholesterol synthesis axis is associated with outcome in pancreatic cancer. Clin Cancer Res. 2020, 26:135-46. 10.1158\/1078-0432.CCR-19-1543","journal-title":"Clin Cancer Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.04.025","article-title":"Fasting blood glucose levels provide estimate of duration and progression of pancreatic cancer before diagnosis","volume":"155","author":"Sharma A","year":"2018","unstructured":"Sharma A, Smyrk TC, Levy MJ, Topazian MA, Chari ST. Fasting blood glucose levels provide estimate of duration and progression of pancreatic cancer before diagnosis. Gastroenterology. 2018, 155:490-500.e2. 10.1053\/j.gastro.2018.04.025","journal-title":"Gastroenterology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102193","article-title":"Blood biomarkers for differential diagnosis and early detection of pancreatic cancer","volume":"96","author":"Al-Shaheri FN","year":"2021","unstructured":"Al-Shaheri FN, Alhamdani MS, Bauer AS, Giese N, B\u00fcchler MW, Hackert T, Hoheisel JD. Blood biomarkers for differential diagnosis and early detection of pancreatic cancer. Cancer Treat Rev. 2021, 96:102193. 10.1016\/j.ctrv.2021.102193","journal-title":"Cancer Treat Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1039\/b906712b","article-title":"Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy","volume":"40","author":"Dunn WB","year":"2011","unstructured":"Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev. 2011, 40:387-426. 10.1039\/b906712b","journal-title":"Chem Soc Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.113.076133","article-title":"The food metabolome: a window over dietary exposure","volume":"99","author":"Scalbert A","year":"2014","unstructured":"Scalbert A, Brennan L, Manach C, et al.. The food metabolome: a window over dietary exposure. Am J Clin Nutr. 2014, 99:1286-308. 10.3945\/ajcn.113.076133","journal-title":"Am J Clin Nutr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-017-1242-7","article-title":"Navigating freely-available software tools for metabolomics analysis","volume":"13","author":"Spicer R","year":"2017","unstructured":"Spicer R, Salek RM, Moreno P, Ca\u00f1ueto D, Steinbeck C. Navigating freely-available software tools for metabolomics analysis. Metabolomics. 2017, 13:106. 10.1007\/s11306-017-1242-7","journal-title":"Metabolomics"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/metabo9070123","article-title":"NMR spectroscopy for metabolomics research","volume":"9","author":"Emwas AH","year":"2019","unstructured":"Emwas AH, Roy R, McKay RT, et al.. NMR spectroscopy for metabolomics research. Metabolites. 2019, 9:10.3390\/metabo9070123","journal-title":"Metabolites"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-016-1094-6","article-title":"Metabolomics enables precision medicine: \u2018A White Paper, Community Perspective\u2019","volume":"12","author":"Beger RD","year":"2016","unstructured":"Beger RD, Dunn W, Schmidt MA, et al.. Metabolomics enables precision medicine: \u2018A White Paper, Community Perspective\u2019. Metabolomics. 2016, 12:149. 10.1007\/s11306-016-1094-6","journal-title":"Metabolomics"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-016-0712-6","article-title":"Cancer stem cell metabolism","volume":"18","author":"Peiris-Pag\u00e8s M","year":"2016","unstructured":"Peiris-Pag\u00e8s M, Martinez-Outschoorn UE, Pestell RG, Sotgia F, Lisanti MP. Cancer stem cell metabolism. Breast Cancer Res. 2016, 18:55. 10.1186\/s13058-016-0712-6","journal-title":"Breast Cancer Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"Cohen JD","year":"2018","unstructured":"Cohen JD, Li L, Wang Y, et al.. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science. 2018, 359:926-30. 10.1126\/science.aar3247","journal-title":"Science"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda C","year":"2014","unstructured":"Bettegowda C, Sausen M, Leary RJ, et al.. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014, 6:224ra24. 10.1126\/scitranslmed.3007094","journal-title":"Sci Transl Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.12.006","article-title":"Employing metabolism to improve the diagnosis and treatment of pancreatic cancer","volume":"31","author":"Halbrook CJ","year":"2017","unstructured":"Halbrook CJ, Lyssiotis CA. Employing metabolism to improve the diagnosis and treatment of pancreatic cancer\r\n. Cancer Cell. 2017, 31:5-19. 10.1016\/j.ccell.2016.12.006","journal-title":"Cancer Cell"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-1212","article-title":"A stromal lysolipid-autotaxin signaling axis promotes pancreatic tumor progression","volume":"9","author":"Auciello FR","year":"2019","unstructured":"Auciello FR, Bulusu V, Oon C, et al.. A stromal lysolipid-autotaxin signaling axis promotes pancreatic tumor progression. Cancer Discov. 2019, 9:617-27. 10.1158\/2159-8290.CD-18-1212","journal-title":"Cancer Discov"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-1134","article-title":"The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression","volume":"8","author":"Pushalkar S","year":"2018","unstructured":"Pushalkar S, Hundeyin M, Daley D, et al.. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discov. 2018, 8:403-16. 10.1158\/2159-8290.CD-17-1134","journal-title":"Cancer Discov"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.01.005","article-title":"The paradox of hypoxic and oxidative stress in atherosclerosis","volume":"51","author":"Mayr M","year":"2008","unstructured":"Mayr M, Sidibe A, Zampetaki A. The paradox of hypoxic and oxidative stress in atherosclerosis. J Am Coll Cardiol. 2008, 51:1266-7. 10.1016\/j.jacc.2008.01.005","journal-title":"J Am Coll Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0810-z","article-title":"Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients","volume":"15","author":"Battini S","year":"2017","unstructured":"Battini S, Faitot F, Imperiale A, et al.. Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients. BMC Med. 2017, 15:56. 10.1186\/s12916-017-0810-z","journal-title":"BMC Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/277977-metabolite-biomarkers-for-early-detection-of-pancreatic-ductal-adenocarcinoma-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T23:14:34Z","timestamp":1732662874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/277977-metabolite-biomarkers-for-early-detection-of-pancreatic-ductal-adenocarcinoma-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.74528","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,26]]}}}